Lionco Pharmaceutical Group Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 126 million compared to CNY 273.97 million a year ago. Revenue was CNY 126 million compared to CNY 273.97 million a year ago. Net income was CNY 20.56 million compared to CNY 35.11 million a year ago. Basic earnings per share from continuing operations was CNY 0.03 compared to CNY 0.05 a year ago. Diluted earnings per share from continuing operations was CNY 0.03 compared to CNY 0.05 a year ago.